Zydus Wellness 1:5 Stock Split Record Date is Tomorrow, Sept 18

Zydus Wellness Limited has announced a stock split to make its shares more affordable and enhance market participation. The company has fixed Thursday, September 18, 2025, as the record date to determine shareholder eligibility for the subdivision.

Details of the Split

The approved corporate action involves splitting each equity share of face value ₹10 into five equity shares of ₹2 each, fully paid-up. This move was approved by the members at the company’s 31st Annual General Meeting (AGM) held on July 30, 2025. 

After the split, the number of outstanding shares will increase fivefold, while the overall capital structure remains unchanged.

A stock split does not change the overall value of an investor’s holding but increases the number of shares owned. For example, if a shareholder holds 100 shares of Zydus Wellness with a face value of ₹10 each, after the 1:5 split, they will hold 500 shares with a face value of ₹2 each.

The total investment value remains the same, but the lower price per share generally makes the stock more attractive to retail investors and enhances liquidity in the market.

Zydus Wellness Share Price Performance

On September 16, 2025, Zydus Wellness share price (NSE: ZYDUSWELL) opened at ₹2,550.00 and closed at ₹2,603.50, up by 2.27%. The stock price touched its day’s high at ₹2,625.00.

Also Read: Dividends & Bonus Issue This Week (Sept 15–19, 2025)!

Previous Dividends

Zydus Wellness had also declared a final dividend of ₹6 per share in July 2025 and ₹5 per share in July 2024, reflecting its commitment to rewarding shareholders.

Conclusion

The upcoming stock split is expected to improve trading volumes and investor participation, aligning with Zydus Wellness’ strategy to enhance shareholder value.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.